NCCN upgraded support to category 2A for BCG-unresponsive high-grade papillary Ta/T1 without CIS, while maintaining category ...
This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance ...
Walking into an emergency room is a bit like stepping onto a stage where anything can happen, except the actors don’t always ...
In the first post of this series, I described what happens to the human body at ground zero of a 10 to 15-kiloton nuclear detonation: the zone within 800 meters of the hypocenter. There, the thermal ...
The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how effectively the two are integrated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results